{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:58:03Z","timestamp":1791313083356,"version":"4.3.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T00:00:00Z","timestamp":1723766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T00:00:00Z","timestamp":1723766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-024-05578-w","type":"journal-article","created":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T00:02:26Z","timestamp":1723766546000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["The compositional and functional imbalance of the gut microbiota in CKD linked to disease patterns"],"prefix":"10.1186","volume":"22","author":[{"given":"Jing","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaixin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjie","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiu-chang","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0251-0170","authenticated-orcid":false,"given":"Ying","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,16]]},"reference":[{"issue":"1","key":"5578_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","volume":"12","author":"CP Kovesdy","year":"2022","unstructured":"Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl (2011). 2022;12(1):7\u201311.","journal-title":"Kidney Int Suppl (2011)"},{"issue":"10225","key":"5578_CR2","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","volume":"395","author":"GBD Chronic Kidney Disease Collaboration","year":"2020","unstructured":"GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709\u201333.","journal-title":"Lancet"},{"key":"5578_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2024.106990","volume":"142","author":"P Bouwmans","year":"2024","unstructured":"Bouwmans P, Malahe SRK, Messchendorp AL, Vart P, Imhof C, Sanders JF, Gansevoort RT, de Vries APJ, Abrahams AC, Bemelman FJ, Vervoort JPM, Hilbrands LB, Ten Dam MAGJ, van den Dorpel RMA, Rispens T, Steenhuis M, Reinders MEJ, Hemmelder MH, RECOVAC Consortium. Post COVID-19 condition imposes significant burden in patients with advanced chronic kidney disease: a nested case-control study. Int J Infect Dis. 2024;142: 106990.","journal-title":"Int J Infect Dis"},{"issue":"1","key":"5578_CR4","doi-asserted-by":"publisher","first-page":"sfad283","DOI":"10.1093\/ckj\/sfad283","volume":"17","author":"A Artborg","year":"2023","unstructured":"Artborg A, Caldinelli A, Wijkstr\u00f6m J, Nowak A, Fored M, Stendahl M, Evans M, Rydell H. Risk factors for COVID-19 hospitalization and mortality in patients with chronic kidney disease: a nationwide cohort study. Clin Kidney J. 2023;17(1):sfad283.","journal-title":"Clin Kidney J"},{"issue":"11","key":"5578_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030442","volume":"3","author":"CD Mathers","year":"2006","unstructured":"Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11): e442.","journal-title":"PLoS Med"},{"issue":"10159","key":"5578_CR6","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1016\/S0140-6736(18)31694-5","volume":"392","author":"KJ Foreman","year":"2018","unstructured":"Foreman KJ, Marquez N, Dolgert A, Fukutaki K, Fullman N, McGaughey M, Pletcher MA, Smith AE, Tang K, Yuan CW, Brown JC, Friedman J, He J, Heuton KR, Holmberg M, Patel DJ, Reidy P, Carter A, Cercy K, Chapin A, Douwes-Schultz D, Frank T, Goettsch F, Liu PY, Nandakumar V, Reitsma MB, Reuter V, Sadat N, Sorensen RJD, Srinivasan V, Updike RL, York H, Lopez AD, Lozano R, Lim SS, Mokdad AH, Vollset SE, Murray CJL. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016\u201340 for 195 countries and territories. Lancet. 2018;392(10159):2052\u201390.","journal-title":"Lancet"},{"issue":"1","key":"5578_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40168-022-01443-4","volume":"11","author":"H Wang","year":"2023","unstructured":"Wang H, Ainiwaer A, Song Y, Qin L, Peng A, Bao H, Qin H. Perturbed gut microbiome and fecal and serum metabolomes are associated with chronic kidney disease severity. Microbiome. 2023;11(1):3.","journal-title":"Microbiome"},{"issue":"1","key":"5578_CR8","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s13059-023-03056-y","volume":"24","author":"P Zhang","year":"2023","unstructured":"Zhang P, Wang X, Li S, Cao X, Zou J, Fang Y, Shi Y, Xiang F, Shen B, Li Y, Fang B, Zhang Y, Guo R, Lv Q, Zhang L, Lu Y, Wang Y, Yu J, Xie Y, Wang R, Chen X, Yu J, Zhang Z, He J, Zhan J, Lv W, Nie Y, Cai J, Xu X, Hu J, Zhang Q, Gao T, Jiang X, Tan X, Xue N, Wang Y, Ren Y, Wang L, Zhang H, Ning Y, Chen J, Zhang L, Jin S, Ren F, Ehrlich SD, Zhao L, Ding X. Metagenome-wide analysis uncovers gut microbial signatures and implicates taxon-specific functions in end-stage renal disease. Genome Biol. 2023;24(1):226.","journal-title":"Genome Biol"},{"issue":"2","key":"5578_CR9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41581-022-00647-z","volume":"19","author":"H Krukowski","year":"2023","unstructured":"Krukowski H, Valkenburg S, Madella AM, Garssen J, van Bergenhenegouwen J, Overbeek SA, Huys GRB, Raes J, Glorieux G. Gut microbiome studies in CKD: opportunities, pitfalls and therapeutic potential. Nat Rev Nephrol. 2023;19(2):87\u2013101.","journal-title":"Nat Rev Nephrol"},{"issue":"28","key":"5578_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202201581","volume":"9","author":"J Shang","year":"2022","unstructured":"Shang J, Zhang Y, Guo R, Liu W, Zhang J, Yan G, Wu F, Cui W, Wang P, Zheng X, Wang T, Dong Y, Zhao J, Wang L, Xiao J, Zhao Z. Gut microbiome analysis can be used as a noninvasive diagnostic tool and plays an essential role in the onset of membranous nephropathy. Adv Sci (Weinh). 2022;9(28): e2201581.","journal-title":"Adv Sci (Weinh)"},{"issue":"12","key":"5578_CR11","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1681\/ASN.2022020189","volume":"33","author":"J Zhao","year":"2022","unstructured":"Zhao J, Bai M, Ning X, Qin Y, Wang Y, Yu Z, Dong R, Zhang Y, Sun S. Expansion of Escherichia-Shigella in gut is associated with the onset and response to immunosuppressive therapy of IgA nephropathy. J Am Soc Nephrol. 2022;33(12):2276\u201392.","journal-title":"J Am Soc Nephrol"},{"key":"5578_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.843695","volume":"13","author":"J Hu","year":"2022","unstructured":"Hu J, Wei S, Gu Y, Wang Y, Feng Y, Sheng J, Hu L, Gu C, Jiang P, Tian Y, Guo W, Lv L, Liu F, Zou Y, Yan F, Feng N. Gut mycobiome in patients with chronic kidney disease was altered and associated with immunological profiles. Front Immunol. 2022;13: 843695.","journal-title":"Front Immunol"},{"issue":"4","key":"5578_CR13","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2024","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105(4):S117\u2013314.","journal-title":"Kidney Int"},{"issue":"5","key":"5578_CR14","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1681\/ASN.2015060612","volume":"27","author":"S Sethi","year":"2016","unstructured":"Sethi S, Haas M, Markowitz GS, D\u2019Agati VD, Rennke HG, Jennette JC, Bajema IM, Alpers CE, Chang A, Cornell LD, Cosio FG, Fogo AB, Glassock RJ, Hariharan S, Kambham N, Lager DJ, Leung N, Mengel M, Nath KA, Roberts IS, Rovin BH, Seshan SV, Smith RJ, Walker PD, Winearls CG, Appel GB, Alexander MP, Cattran DC, Casado CA, Cook HT, De Vriese AS, Radhakrishnan J, Racusen LC, Ronco P, Fervenza FC. Mayo clinic\/renal pathology society consensus report on pathologic classification, diagnosis, and reporting of GN. J Am Soc Nephrol. 2016;27(5):1278\u201387.","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"5578_CR15","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.humpath.2012.04.009","volume":"43","author":"A Chang","year":"2012","unstructured":"Chang A, Gibson IW, Cohen AH, Weening JW, Jennette JC, Fogo AB, Renal Pathology Society. A position paper on standardizing the nonneoplastic kidney biopsy report. Hum Pathol. 2012;43(8):1192\u20136.","journal-title":"Hum Pathol"},{"issue":"1","key":"5578_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.85","volume":"2","author":"F Lyu","year":"2023","unstructured":"Lyu F, Han F, Ge C, Mao W, Chen L, Hu H, Chen G, Lang Q, Fang C. OmicStudio: a composable bioinformatics cloud platform with real-time feedback that can generate high-quality graphs for publication. Imeta. 2023;2(1): e85.","journal-title":"Imeta"},{"issue":"1","key":"5578_CR17","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12882-022-02797-5","volume":"23","author":"M Li","year":"2022","unstructured":"Li M, Wei L, Sun J, Zhu Q, Yang H, Zhang Y, Zhang C, Xi L, Zhao R, Du X. Association of gut microbiota with idiopathic membranous nephropathy. BMC Nephrol. 2022;23(1):164.","journal-title":"BMC Nephrol"},{"issue":"6","key":"5578_CR18","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/00325481.2020.1744335","volume":"132","author":"X Hu","year":"2020","unstructured":"Hu X, Ouyang S, Xie Y, Gong Z, Du J. Characterizing the gut microbiota in patients with chronic kidney disease. Postgrad Med. 2020;132(6):495\u2013505.","journal-title":"Postgrad Med"},{"issue":"5","key":"5578_CR19","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1093\/advances\/nmz028","volume":"10","author":"S Chung","year":"2019","unstructured":"Chung S, Barnes JL, Astroth KS. Gastrointestinal microbiota in patients with chronic kidney disease: a systematic review. Adv Nutr. 2019;10(5):888\u2013901.","journal-title":"Adv Nutr"},{"issue":"20","key":"5578_CR20","doi-asserted-by":"publisher","first-page":"2001936","DOI":"10.1002\/advs.202001936","volume":"7","author":"Z Ren","year":"2020","unstructured":"Ren Z, Fan Y, Li A, Shen Q, Wu J, Ren L, Lu H, Ding S, Ren H, Liu C, Liu W, Gao D, Wu Z, Guo S, Wu G, Liu Z, Yu Z, Li L. Alterations of the human gut microbiome in chronic kidney disease. Adv Sci (Weinh). 2020;7(20):2001936.","journal-title":"Adv Sci (Weinh)"},{"issue":"4","key":"5578_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0228530","volume":"15","author":"E Margiotta","year":"2020","unstructured":"Margiotta E, Miragoli F, Callegari ML, Vettoretti S, Caldiroli L, Meneghini M, Zanoni F, Messa P. Gut microbiota composition and frailty in elderly patients with Chronic Kidney Disease. PLoS ONE. 2020;15(4): e0228530.","journal-title":"PLoS ONE"},{"issue":"1","key":"5578_CR22","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3390\/cells10010114","volume":"10","author":"CY Yang","year":"2021","unstructured":"Yang CY, Chen TW, Lu WL, Liang SS, Huang HD, Tseng CP, Tarng DC. Synbiotics alleviate the gut indole load and dysbiosis in chronic kidney disease. Cells. 2021;10(1):114.","journal-title":"Cells"},{"issue":"10","key":"5578_CR23","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1007\/s10482-016-0737-y","volume":"109","author":"S Jiang","year":"2016","unstructured":"Jiang S, Xie S, Lv D, Zhang Y, Deng J, Zeng L, Chen Y. A reduction in the butyrate producing species Roseburia spp. and Faecalibacterium prausnitzii is associated with chronic kidney disease progression. Antonie Van Leeuwenhoek. 2016;109(10):1389\u201396.","journal-title":"Antonie Van Leeuwenhoek"},{"issue":"1","key":"5578_CR24","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s12967-019-1969-1","volume":"17","author":"Y Li","year":"2019","unstructured":"Li Y, Su X, Zhang L, Liu Y, Shi M, Lv C, Gao Y, Xu D, Wang Z. Dysbiosis of the gut microbiome is associated with CKD5 and correlated with clinical indices of the disease: a case-controlled study. J Transl Med. 2019;17(1):228.","journal-title":"J Transl Med"},{"issue":"1","key":"5578_CR25","doi-asserted-by":"publisher","first-page":"2186685","DOI":"10.1080\/19490976.2023.2186685","volume":"15","author":"BA Peters","year":"2023","unstructured":"Peters BA, Qi Q, Usyk M, Daviglus ML, Cai J, Franceschini N, Lash JP, Gellman MD, Yu B, Boerwinkle E, Knight R, Burk RD, Kaplan RC. Association of the gut microbiome with kidney function and damage in the Hispanic Community Health Study\/Study of Latinos (HCHS\/SOL). Gut Microbes. 2023;15(1):2186685.","journal-title":"Gut Microbes"},{"issue":"9","key":"5578_CR26","doi-asserted-by":"publisher","first-page":"e120","DOI":"10.1161\/CIRCRESAHA.122.320184","volume":"131","author":"HB Li","year":"2022","unstructured":"Li HB, Xu ML, Xu XD, Tang YY, Jiang HL, Li L, Xia WJ, Cui N, Bai J, Dai ZM, Han B, Li Y, Peng B, Dong YY, Aryal S, Manandhar I, Eladawi MA, Shukla R, Kang YM, Joe B, Yang T. Faecalibacterium prausnitzii attenuates CKD via butyrate-renal GPR43 axis. Circ Res. 2022;131(9):e120\u201334.","journal-title":"Circ Res"},{"key":"5578_CR27","doi-asserted-by":"publisher","first-page":"1241215","DOI":"10.3389\/fvets.2023.1241215","volume":"10","author":"KR Kim","year":"2023","unstructured":"Kim KR, Kim SM, Kim JH. A pilot study of alterations of the gut microbiome in canine chronic kidney disease. Front Vet Sci. 2023;10:1241215.","journal-title":"Front Vet Sci"},{"issue":"17","key":"5578_CR28","doi-asserted-by":"publisher","first-page":"3881","DOI":"10.3390\/jcm10173881","volume":"10","author":"TH Chen","year":"2021","unstructured":"Chen TH, Liu CW, Ho YH, Huang CK, Hung CS, Smith BH, Lin JC. Gut microbiota composition and its metabolites in different stages of chronic kidney disease. J Clin Med. 2021;10(17):3881.","journal-title":"J Clin Med"},{"key":"5578_CR29","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3389\/fcimb.2019.00206","volume":"9","author":"F Li","year":"2019","unstructured":"Li F, Wang M, Wang J, Li R, Zhang Y. Alterations to the gut microbiota and their correlation with inflammatory factors in chronic kidney disease. Front Cell Infect Microbiol. 2019;9:206.","journal-title":"Front Cell Infect Microbiol"},{"key":"5578_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2020.104359","volume":"147","author":"J Zhang","year":"2020","unstructured":"Zhang J, Luo D, Lin Z, Zhou W, Rao J, Li Y, Wu J, Peng H, Lou T. Dysbiosis of gut microbiota in adult idiopathic membranous nephropathy with nephrotic syndrome. Microb Pathog. 2020;147: 104359.","journal-title":"Microb Pathog"},{"key":"5578_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2022.105891","volume":"174","author":"T Pei","year":"2023","unstructured":"Pei T, Hu R, Wang F, Yang S, Feng H, Li Q, Zhang J, Yan S, Ju L, He Z, Han Z, Yang A, Xiao W, Ma Y, Wang M. Akkermansia muciniphila ameliorates chronic kidney disease interstitial fibrosis via the gut-renal axis. Microb Pathog. 2023;174: 105891.","journal-title":"Microb Pathog"},{"issue":"5","key":"5578_CR32","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41581-019-0118-7","volume":"15","author":"F Knauf","year":"2019","unstructured":"Knauf F, Brewer JR, Flavell RA. Immunity, microbiota and kidney disease. Nat Rev Nephrol. 2019;15(5):263\u201374.","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"5578_CR33","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.kint.2024.01.040","volume":"105","author":"J Lee","year":"2024","unstructured":"Lee J, Lee J, Kim K, Lee J, Jung Y, Hyeon JS, Seo A, Jin W, Weon B, Shin N, Kim S, Lim CS, Kim YS, Lee JP, Hwang GS, Yang SH. Antibiotic-induced intestinal microbiota depletion can attenuate the acute kidney injury to chronic kidney disease transition via NADPH oxidase 2 and trimethylamine-N-oxide inhibition. Kidney Int. 2024;105(6):1239\u201353.","journal-title":"Kidney Int"},{"issue":"1","key":"5578_CR34","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.yexcr.2017.02.001","volume":"352","author":"X Zhou","year":"2017","unstructured":"Zhou X, Yao Q, Sun X, Gong X, Yang Y, Chen C, Shan G. Slit2 ameliorates renal inflammation and fibrosis after hypoxia-and lipopolysaccharide-induced epithelial cells injury in vitro. Exp Cell Res. 2017;352(1):123\u20139.","journal-title":"Exp Cell Res"},{"key":"5578_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2020.104583","volume":"152","author":"K Suganya","year":"2021","unstructured":"Suganya K, Son T, Kim KW, Koo BS. Impact of gut microbiota: How it could play roles beyond the digestive system on development of cardiovascular and renal diseases. Microb Pathog. 2021;152: 104583.","journal-title":"Microb Pathog"},{"key":"5578_CR36","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1038\/ki.2009.403","volume":"114","author":"PP Sun","year":"2009","unstructured":"Sun PP, Perianayagam MC, Jaber BL. Endotoxin-binding affinity of sevelamer: a potential novel anti-inflammatory mechanism. Kidney Int Suppl. 2009;114:S20\u20135.","journal-title":"Kidney Int Suppl"},{"issue":"9","key":"5578_CR37","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.3390\/nu12092799","volume":"12","author":"IW Wu","year":"2020","unstructured":"Wu IW, Lee CC, Hsu HJ, Sun CY, Chen YC, Yang KJ, Yang CW, Chung WH, Lai HC, Chang LC, Su SC. Compositional and functional adaptations of intestinal microbiota and related metabolites in CKD patients receiving dietary protein restriction. Nutrients. 2020;12(9):2799.","journal-title":"Nutrients"},{"key":"5578_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000445460","volume":"188","author":"M Meola","year":"2016","unstructured":"Meola M, Nalesso F, Petrucci I, Samoni S, Ronco C. Pathophysiology and clinical work-up of acute kidney injury. Contrib Nephrol. 2016;188:1\u201310.","journal-title":"Contrib Nephrol"},{"key":"5578_CR39","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.bios.2018.09.067","volume":"123","author":"CS Pundir","year":"2019","unstructured":"Pundir CS, Jakhar S, Narwal V. Determination of urea with special emphasis on biosensors: a review. Biosens Bioelectron. 2019;123:36\u201350.","journal-title":"Biosens Bioelectron"},{"issue":"6","key":"5578_CR40","doi-asserted-by":"publisher","first-page":"983","DOI":"10.2215\/CJN.11761116","volume":"12","author":"WG Couser","year":"2017","unstructured":"Couser WG. Primary membranous nephropathy. Clin J Am Soc Nephrol. 2017;12(6):983\u201397.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"Suppl 11","key":"5578_CR41","doi-asserted-by":"publisher","first-page":"C173","DOI":"10.12968\/hmed.2014.75.Sup11.C173","volume":"75","author":"C Cheung","year":"2014","unstructured":"Cheung C, Bashir S, Barratt J. IgA nephropathy. Br J Hosp Med (Lond). 2014;75(Suppl 11):C173\u20136.","journal-title":"Br J Hosp Med (Lond)"},{"issue":"2","key":"5578_CR42","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2215\/CJN.05000516","volume":"12","author":"M Vivarelli","year":"2017","unstructured":"Vivarelli M, Massella L, Ruggiero B, Emma F. Minimal change disease. Clin J Am Soc Nephrol. 2017;12(2):332\u201345.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"5578_CR43","first-page":"432","volume":"32","author":"M Adamczak","year":"2012","unstructured":"Adamczak M, Wiecek A. Ischemic nephropathy\u2014pathogenesis and treatment. Nefrologia. 2012;32(4):432\u20138.","journal-title":"Nefrologia"},{"issue":"4","key":"5578_CR44","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/nrneph.2011.16","volume":"7","author":"AA Sharfuddin","year":"2011","unstructured":"Sharfuddin AA, Molitoris BA. Pathophysiology of ischemic acute kidney injury. Nat Rev Nephrol. 2011;7(4):189\u2013200.","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"5578_CR45","doi-asserted-by":"publisher","first-page":"H349","DOI":"10.1152\/ajpheart.00759.2016","volume":"312","author":"UO Wenzel","year":"2017","unstructured":"Wenzel UO, Bode M, K\u00f6hl J, Ehmke H. A pathogenic role of complement in arterial hypertension and hypertensive end organ damage. Am J Physiol Heart Circ Physiol. 2017;312(3):H349\u201354.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"5578_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.557368","volume":"10","author":"R Dong","year":"2020","unstructured":"Dong R, Bai M, Zhao J, Wang D, Ning X, Sun S. A comparative study of the gut microbiota associated with immunoglobulin a nephropathy and membranous nephropathy. Front Cell Infect Microbiol. 2020;10: 557368.","journal-title":"Front Cell Infect Microbiol"},{"issue":"732","key":"5578_CR47","doi-asserted-by":"publisher","first-page":"eadg8357","DOI":"10.1126\/scitranslmed.adg8357","volume":"16","author":"AA Verdegaal","year":"2024","unstructured":"Verdegaal AA, Goodman AL. Integrating the gut microbiome and pharmacology. Sci Transl Med. 2024;16(732):eadg8357.","journal-title":"Sci Transl Med"},{"issue":"2","key":"5578_CR48","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.179","volume":"3","author":"H Ren","year":"2024","unstructured":"Ren H, Shi Z, Yang F, Wang S, Yuan F, Li T, Li M, Zhu J, Li J, Wu K, Zhang Y, Ning G, Kristiansen K, Wang W, Gu Y, Zhong H. Deciphering unique and shared interactions between the human gut microbiota and oral antidiabetic drugs. Imeta. 2024;3(2): e179.","journal-title":"Imeta"},{"issue":"9","key":"5578_CR49","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1111\/bph.15768","volume":"179","author":"Y Li","year":"2022","unstructured":"Li Y, Zhao D, Qian M, Liu J, Pan C, Zhang X, Duan X, Zhang Y, Jia W, Wang L. Amlodipine, an anti-hypertensive drug, alleviates non-alcoholic fatty liver disease by modulating gut microbiota. Br J Pharmacol. 2022;179(9):2054\u201377.","journal-title":"Br J Pharmacol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05578-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-024-05578-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05578-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T01:02:54Z","timestamp":1723770174000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-024-05578-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,16]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5578"],"URL":"https:\/\/doi.org\/10.1186\/s12967-024-05578-w","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,16]]},"assertion":[{"value":"3 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved (Permit No. 2023-ke-730) by the Medical Ethics Committee of Beijing Chaoyang Hospital (Capital Medical University, Beijing, China) and was conducted in accordance with the principles of the Helsinki Declaration. Written informed consent was obtained from all patients prior to enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflicts of interest related to this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"773"}}